09/09/2019
6:30 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2019
7:45 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2019
3:22 PM | Aclaris Therapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G
| |
08/08/2019
4:01 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2019
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2019
6:18 AM | Aclaris Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G/A
| |
07/30/2019
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2019
3:33 PM | Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SC 13G
| |
07/09/2019
4:11 PM | Aclaris Therapeutics (Subject)
Man Group plc (Filed by)
| Form SC 13G
| |
07/03/2019
3:47 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
3:46 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2019
3:44 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2019
4:01 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
4:52 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
5:31 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
5:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2019
4:47 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:56 PM | Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:52 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:51 PM | Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:50 PM | Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:49 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
6:00 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2019
6:01 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2019
4:24 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2019
4:01 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2019
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2019
6:10 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A
| |
04/25/2019
6:02 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A
| |
04/04/2019
6:06 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2019
3:38 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/18/2019
7:01 AM | Aclaris Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2019
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2019
5:13 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
5:12 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
5:11 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
5:10 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
5:09 PM | Aclaris Therapeutics (Issuer)
Shanler Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
2:35 PM | Aclaris Therapeutics (Subject)
VIVO VENTURES VII, LLC (Filed by)
| Form SC 13D/A
| |
02/08/2019
4:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2019
5:34 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2019
5:33 PM | Aclaris Therapeutics (Issuer)
Powala Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2019
5:32 PM | Aclaris Therapeutics (Issuer)
Shanler Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2019
5:31 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2019
5:30 PM | Aclaris Therapeutics (Issuer)
Fair Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2019
5:29 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
3:22 PM | Aclaris Therapeutics (Subject)
Broadfin Capital, LLC (Filed by)
| Form SC 13G
| |
01/25/2019
1:12 PM | Aclaris Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A
| |
01/18/2019
3:34 PM | Aclaris Therapeutics (Filer)
| Form 8-K/A
| |
01/18/2019
1:55 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:33 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2018
6:07 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
6:16 PM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
6:34 AM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
6:33 AM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
6:32 AM | Aclaris Therapeutics (Issuer)
Shanler Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
6:31 AM | Aclaris Therapeutics (Issuer)
Fair Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
6:29 AM | Aclaris Therapeutics (Issuer)
Powala Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2018
8:59 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2018
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2018
7:54 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2018
7:54 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2018
7:53 PM | Aclaris Therapeutics (Issuer)
Shanler Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2018
7:52 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2018
7:51 PM | Aclaris Therapeutics (Issuer)
Powala Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2018
7:51 PM | Aclaris Therapeutics (Issuer)
Fair Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2018
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2018
8:02 AM | Aclaris Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
12/03/2018
3:16 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2018
4:01 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2018
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2018
3:01 PM | Aclaris Therapeutics (Subject)
D. E. SHAW & CO, L.P. (Filed by)
| Form SC 13G
| |
10/31/2018
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2018
9:18 AM | Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2018
9:13 AM | Aclaris Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G/A
| |
10/23/2018
6:13 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2018
3:08 PM | Aclaris Therapeutics (Filer)
| Form 424B5
| |
10/18/2018
3:01 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2018
7:43 PM | Aclaris Therapeutics (Filer)
| Form S-3MEF
| |
10/17/2018
3:04 PM | Aclaris Therapeutics (Filer)
| Form 424B5
| |
10/15/2018
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2018
3:37 PM | Aclaris Therapeutics (Issuer)
Tullman Stephen A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2018
4:00 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2018
3:55 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/27/2018
3:46 PM | Aclaris Therapeutics (Issuer)
Tullman Stephen A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2018
3:55 PM | Aclaris Therapeutics (Issuer)
Tullman Stephen A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2018
1:24 PM | Aclaris Therapeutics (Filer)
| Form D/A
| |
08/03/2018
7:16 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2018
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2018
9:52 AM | Aclaris Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
06/12/2018
5:42 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
6:22 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2018
2:41 PM | Aclaris Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A
| |
05/21/2018
3:06 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2018
6:34 PM | Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2018
8:28 AM | Aclaris Therapeutics (Filer)
| Form CT ORDER
| |
05/09/2018
3:22 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2018
3:21 PM | Aclaris Therapeutics (Issuer)
Shanler Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2018
3:20 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
